Zika virus and the never-ending story of emerging pathogens and transfusion medicine.
Blood Transfus. 2015 Nov V.5 P.1-6.
Marano G1, Pupella S1, Vaglio S1,2, Liumbruno GM1, Grazzini G1.
1Italian National Blood Centre, National Institute of Health, Rome, Italy.
2Faculty of Medicine and Psychology, “Sapienza” University of Rome, Rome, Italy.
In the last few years, the transfusion medicine community has been paying special attention to emerging vector-borne diseases transmitted by arboviruses. Zika virus is the latest of these pathogens and is responsible for major outbreaks in Africa, Asia and, more recently, in previously infection-naïve territories of the Pacific area. Many issues regarding this emerging pathogen remain unclear and require further investigation. National health authorities have adopted different prevention strategies. The aim of this review article is to discuss the currently available, though limited, information and the potential impact of this virus on transfusion medicine.
PDF (DOWNLOAD CLIC in PDF)
Entry filed under: Biología Molecular, Epidemiología, F.O.D, FIEBRE y RASH, Health Care-Associated Infections, Infecciones emergentes, Infecciones nosocomiales, Infecciones virales, Metodos diagnosticos, REPORTS, Sepsis, Zoonosis.
Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016